Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2023-02-07 00:00:00 ET · period of report 2023-02-03 · accession 0001209191-23-007670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-07 | 2023-02-03 | CTKB | Yan Ming | CTO, Dir | S - Sale | $13.50 | -1,092 | 7.95M | -0.0% | -$14.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | S | D | 11 | $13.51 | 7,945,741 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-03 | S | D | 1,081 | $13.50 | 7,945,752 | D | — | — |